In this study we aimed to determine the prognostic factors affecting local control (LC) in limited glottic carcinoma treated with definitive radiotherapy (RT).
Material and methods
Between June 1991 and December 2001, 114 patients with early squamous-cell carcinoma of the glottis were treated with definitive RT at our institution. Only four (3.5%) patients were women. The median age was 60 (27-79). Fifteen percent, 72% and 13% of the patients had Tis, T1 and T2 tumors, respectively. Forty-three (37.7%) patients had anterior commissure invasion. Prior to RT 35 (31%) patients had undergone vocal cord stripping and two (2%) cordectomy. A median dose of 66 Gy (50-70.2) was given over a median period of 46 days (20-60). Univariate and multivariate analyses were performed for LC. The prognostic parameters analyzed for LC were T classification, anterior commissure involvement, total RT dose, and overall treatment time.
Results
Five-year local and regional control rates were 84.2% and 97.7%. RTOG grade 3-4 late side effects were observed only in one (0.9%) patient. In 15 patients with local failure, salvage treatment consisted of partial laryngectomy in eight patients and total laryngectomy in five. One of the remaining two patients was medically inoperable, and the other refused salvage surgery. In one of the three patients with regional failure, salvage surgery was applied and the other two were given palliative chemotherapy because of unresectable disease. Following salvage treatments, the ultimate five-year LC rate was 96.9% and the five-year larynx preservation rate was 91.1%. Second primary cancer was diagnosed in 17 (14.9%) patients. Only one patient developed distant metastases and two patients died of laryngeal cancer. While T2 disease and anterior commissure involvement were found to be unfavorable prognostic factors significantly influencing LC in univariate analyses, only T2 disease remained independent in multivariate analysis.
Conclusion
In patients with early glottic carcinoma, T classification proved to be the only independent prognostic factor affecting LC after primary radiotherapy according to the results of this study.
JinJ., LiaoZ., GaoL., HuangX., XuG.: Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences.Int J Radiat Oncol Biol Phys, 54: 471–478, 2002.
2.
MarshakG., BrennerB., ShveroJ., ShapiraJ., OphirD., HochmanI., MarshakG., SulkesA., RakowskyE.: Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients.Int J Radiat Oncol Biol Phys, 43: 1009–1013, 1999.
3.
ReddyS.P., MohideenN., MarraS., MarksJ.E.: Effect of tumor bulk on local control and survival of patients with Tl glottic cancer.Radiother Oncol, 47: 161–166, 1997.
4.
O'SullivanB., MackillopW., GilbertR., GazeM., LundgrenJ., AtkinsonC., WynneC., FuH.: Controversies in the management of laryngeal cancer: results of an international survey of patterns of care.Radiother Oncol, 31: 23–32, 1994.
5.
LusinchiA., DubeP., WibaultP., KunklerI., LuboinskiB., EschwegeF.: Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif.Radiother Oncol, 15: 313–319, 1989.
6.
MendenhallW.M., ParsonsJ.T., MillionR.R.: Management of Tl and T2 squamous cell carcinoma of the glottic larynx.Mayo Clin Proc, 67: 703–705, 1992.
7.
SakataK., AokiY., KarasawaK., HasezawaK., MutaN., Naka-gawaK., TeraharaA., OnogiY., SasakiY., AkanumaA.: Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.Int J Radiat Oncol Biol Phys, 30: 1059–1064, 1994.
8.
MendenhallW.M., AmdurR.J., MorrisC.G., HinermanR.W.: T1-2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy.J Clin Oncol, 19: 4029–4036, 2001.
9.
HermansR., FeronM., BellonE., DupontP., Van den BogaertW., BaertA.L.: Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability.Int J Radiat Oncol Biol Phys, 40: 553–557, 1998.
10.
WardeP., O'SullivanB., BristowR.G., PanzarellaT., KeaneT.J., GullaneP.J., WitterickI.P., PayneD., LiuF.F., McLeanM., WaldronJ., CummingsB.J.: T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.Int J Radiat Oncol Biol Phys, 41: 347–353, 1998.
HollandJ.M., ArsanjaniA., LiemB.J., HoffeltS.C., CohenJ.I., StevensKRJr.: Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy.J Laryngol Otol, 116: 190–193, 2002.
13.
BurkeL.S., GrevenK.M., McGuirtW.T., CaseD., HoenH.M., RabenM.: Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.Int J Radiat Oncol Biol Phys, 38: 1001–1006, 1997.
14.
KimR.Y., MarksM.E., SalterM.M.: Early-stage glottic cancer: importance of dose fractionation in radiation therapy.Radiology, 182: 273–275, 1992.
15.
FeinD.A., LeeW.R., HanlonA.L., RidgeJ.A., LangerC.J., CurranW.J.Jr., CoiaL.R.: Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.J Clin Oncol, 13: 2077–2083, 1995.
16.
NarayanaA., VaughanA.T., KathuriaS., FisherS.G., WalterS.A., ReddyS.P.: P53 overexpression is associated with bulky tumor and poor local control in Tl glottic cancer.Int J Radiat Oncol Biol Phys, 46: 21–26, 2000.
17.
MiyaguchiM., OlofssonJ., HellquistH.B.: Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy.Clinical Otolaryngology, 16: 466–469, 1991.
18.
DemiralA.N., SariogluS., BirlikB., SenM., KinayM.: Prognostic significance of EGF receptor expression in early glottic cancer.Auris Nasus Larynx, 31: 417–424, 2004.
19.
SmallW.Jr., MittalB.B., BrandW.N., ShettyR.M., RademakerA.W., BeckG.G., HoowerS.V.: Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables.Radiology, 183: 789–794, 1992.
20.
LeQ.T., FuK.K., KrollS., RyuJ.K., QuiveyJ.M., MeylerT.S., KriegR.M., PhillipsT.L.: Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.Int J Radiat Oncol Biol Phys, 39: 115–126, 1997.
21.
YuE., ShenoudaG., BeaudetM.P., BlackM.J.: Impact of radiation therapy fraction size on local control of early glottic carcinoma.Int J Radiat Oncol Biol Phys, 37: 587–591, 1997.
22.
FeinD.A., LeeW.R., HanlonA.L., RidgeJ.A., CurranW.J., CoiaL.R.: Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?Int J Radiat Oncol Biol Phys, 34: 823–831, 1996.
23.
ZouhairA., AzriaD., CouckeP., MatzingerO., BronL., Moeck-liR., DoH.P., MirimanoffR.O., OzsahinM.: Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.Strahlenther Onkol, 180: 84–90, 2004.
SobinL.H., WittekindC.: TNM classification of malignant tumors,5th ed, pp 33–37, John Wiley & Sons Inc, New York, 1997.
26.
KaplanE.L., MeierP.: Nonparametric estimation from incomplete observations.J Am Stat Assoc, 53: 457–461, 1958.
27.
AltmanD.G.: Principles of statistical analysis. In: Practical statistics for medical research,1st ed, AltmanD.G. (Ed), pp 152–178, Chapman & Hall, London, 1991.
28.
DawsonB., TrappR.G.: Analyzing research questions about survival. In: Basic & clinical biostatistics, 3rd ed, DawsonB., TrappR.G. (Eds), p 218, Lange Medical Books/Mc Graw Hill, New York, 2001.
29.
PetoR., PikeM.C., ArmitageP., BreslowN.E., CoxD.R., HowardS.V., MantelN., McPhersonK., PetoJ., SmithP.G.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.Br J Cancer, 35: 1–39, 1977.
30.
CoxD.R.: Regression models and life-tables.J R Stat Soc, 34: 187–220, 1972.
31.
RudoltzM.S., BenammarA., MohiuddinM.: Prognostic factors for local control and survival in Tl squamous cell carcinoma of the glottis.Int J Radiat Oncol Biol Phys, 26: 767–772, 1993.
32.
StevensonJ.M., JuillardG.J., SelchM.T.: Stages 1 and 2 epidermoid carcinoma of the glottic larynx: involvement of the anterior commissure.Radiology, 182: 797–799, 1992.
33.
RaitiolaH., WigrenT., PukanderJ.: Radiotherapy outcome and prognostic factors in early glottic carcinoma.Auris Nasus Larynx, 27: 153–159, 2000.
34.
KanonierG., FritschE., RainerT., ThumfartW.F.: Radiotherapy in early glottic carcinoma.Ann Otol Rhinol Laryngol, 105: 759–763, 1996.
35.
DubbenH.H., ThamesH.D., Beck-BornholdtH.P.: Tumor volume: a basic and specific response predictor in radiotherapy.Radiother Oncol, 47: 167–174, 1998.
36.
FeinD.A., MendenhallW.M., ParsonsJ.T., MillionR.R.: T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.Int J Radiat Oncol Biol Phys, 25: 605–611, 1993.
37.
BenningerM.S., GillenJ., ThiemeP., JacobsonB., DragovichJ.: Factors associated with recurrence and voice quality following radiation therapy for Tl and T2 glottic carcinomas.Laryngoscope, 104: 294–298, 1994.
38.
SombeckM.D., KalbaughK.J., MendenhallW.M., ParsonsJ.T., SmithS.A., MillionR.R., PaltaJ.R.: Radiotherapy for early vocal cord cancer: a dosimetric analysis of 60CO versus 6 MV photons.Head Neck, 18: 167–173, 1996.
39.
DinshawK.A., SharmaV., AgarwalJ.P., GhoshS., HavaldarR.: Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications.Int J Radiat Oncol Biol Phys, 48: 723–735, 2000.
40.
ParsonsJ.T., GreeneB.D., SpeerT.W., KirkpatrickS.A., BarhorstD.B., YanckowitzT.: Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.Int J Radiat Oncol Biol Phys, 50: 953–959, 2001.
41.
DevineniV.R., KingK., PerezC.: Early glottic carcinoma treated with radiotherapy: Impact of treatment energy on success rate.Int J Radiat Oncol Biol Phys, 24: 106, 1992.
42.
IzunoI., SoneS., OguchiM., KiyonoK., TakeiK.: Treatment of early vocal cord carcinoma with Co60 gamma rays, 8/10 MV X rays, or 4 MV X rays: are the results different?Acta Oncol, 29: 637–639, 1990.
43.
GardenA.S., ForsterK., WongP.F., MorrisonW.H., SchechterN.R., AngK.K.: Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment?Int J Radiat Oncol Biol Phys, 55: 322–328, 2003.
HendryJ.H., RobertsS.A., SlevinN.J., KeaneT.J., BartonM.B., Agren-CronqvistA.: Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada.Radiother Oncol, 31: 14–22, 1994.
46.
SchwaiboldF., ScariatoA., NunnoM., WallnerP.E., LustigR.A., RoubyE., GorsheinD., WengerJ.: The effect of fraction size on control of early glottic cancer.Int J Radiat Oncol Biol Phys, 14: 451–454, 1988.
47.
RobertsT.J., EpsteinB., LeeD.J.: Second neoplasms in patients with carcinomas of the vocal cord: incidence and implications for survival.Int J Radiat Oncol Biol Phys, 21: 583–589, 1991.
48.
FujitaM., RudoltzM.S., CanadyD.J., PatelP., MachtayM., PittardM.Q., MohiuddinM., RegineW.F.: Second malignant neoplasia in patients with Tl glottic cancer treated with radiation.Laryngoscope, 108: 1853–1855, 1998.
49.
Di MartinoE., SellhausB., HausmannR., MinkenbergR., LohmannM., EsthofenM.W.: Survival in second primary malignancies of patients with head and neck cancer.J Laryngol Otol, 116: 831–838, 2002.
